Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.97M | 1.28M | 2.33M | 1.14M | 1.32M |
Total Receivables | 158.80K | 158.80K | 158.80K | 158.80K | 158.80K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 944.10K | 919.10K | 1.04M | 1.15M | 923.20K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 3.08M | 2.36M | 3.53M | 2.45M | 2.40M |
|
|||||
Total Current Assets | 3.08M | 2.36M | 3.53M | 2.45M | 2.40M |
Net Property, Plant & Equipment | 419.50K | 524.90K | 628.50K | 730.20K | 830.20K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 575.80K | 575.80K | 133.30K | 133.30K | 133.30K |
Total Assets | 4.07M | 3.46M | 4.29M | 3.31M | 3.36M |
|
|||||
Total Accounts Payable | 4.66M | 5.20M | 5.84M | 6.67M | 5.21M |
Total Accrued Expenses | 1.77M | 1.56M | 1.59M | 1.64M | 1.59M |
Short-term Debt | 1.65M | 1.65M | 2.66M | 1.65M | 1.65M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 170.90K | 229.10K | 258.50K | 268.70K | 260.60K |
Total Finance Division Other Current Liabilities | 463.60K | 403.20K | 61.30K | 388.60K | 227.20K |
Total Other Current Liabilities | 463.60K | 403.20K | 61.30K | 388.60K | 227.20K |
Total Current Liabilities | 8.72M | 9.04M | 10.42M | 10.61M | 8.94M |
|
|||||
Total Current Liabilities | 8.72M | 9.04M | 10.42M | 10.61M | 8.94M |
Long-Term Debt | 3.00M | 1.00M | -- | -- | -- |
Short-term Debt | 1.65M | 1.65M | 2.66M | 1.65M | 1.65M |
Capital Leases | -- | 5.80K | 42.60K | 96.80K | 166.80K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 73.30K | 87.20K | 21.60K | 235.40K | 61.00K |
Total Liabilities | 11.79M | 10.14M | 10.48M | 10.94M | 9.17M |
|
|||||
Common Stock & APIC | 107.23M | 97.91M | 90.95M | 87.62M | 76.18M |
Retained Earnings | -123.75M | -113.39M | -103.94M | -98.06M | -88.39M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -16.52M | -15.47M | -12.99M | -10.43M | -12.22M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 8.80M | 8.80M | 6.80M | 2.80M | 6.41M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 8.80M | 8.80M | 6.80M | 2.80M | 6.41M |
|
|||||
Total Common Equity | -16.52M | -15.47M | -12.99M | -10.43M | -12.22M |
Total Preferred Equity | 8.80M | 8.80M | 6.80M | 2.80M | 6.41M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -7.72M | -6.67M | -6.19M | -7.63M | -5.80M |
|